$24.930
+0.763 (+3.06%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BEAM por análisis de gráficos similares
Alphio's BEAM stock price prediction model matches the current Beam Therapeutics Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $24.93 (+0.01%). The 1-week path is $25.10 (+0.67%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Beam Therapeutics Inc.?
Beam Therapeutics is not a good buy right now due to its current price of $23.47, which is significantly below the analyst price target of $43. The stock has a low RSI of 36.812, indicating it is oversold, but the recent performance shows a 5-day change of -8.68% and a year-to-date change of -13.52%. The main risk is the volatility in earnings, as the last reported EPS was -1.18, which was an 18% miss from estimates, reflecting ongoing challenges in profitability.
BEAM cerró en $24.93 el Tuesday, tras subir +3.06%
Beam Therapeutics Inc. (BEAM) last closed at $24.93, gaining +3.06%. These facts feed the 1-day and 1-week BEAM price prediction above.
Factores de la previsión
Los factores de la previsión de Beam Therapeutics Inc. (BEAM) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BEAM, ordenadas por similitud.
Análisis de estacionalidad de BEAM
Historically the probability of a positive October return for BEAM is 35.00%. February offers the highest probability of a positive month at 84.48%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BEAM
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $13.73 | $13.79 | $19.04 | -44.69% |
| Nov 2026 | $13.49 | $15.16 | $16.84 | -39.20% |
| Dec 2026 | $11.13 | $12.36 | $14.05 | -50.41% |
En 2026, se proyecta que Beam Therapeutics Inc. (BEAM) oscile entre $11.13 y $19.04.
Previsión mensual de Beam Therapeutics Inc. para 2026
En Oct de 2026, se proyecta que Beam Therapeutics Inc. promedie $13.79, con un mínimo de $13.73 y un máximo de $19.04.
En Nov de 2026, se proyecta que Beam Therapeutics Inc. promedie $15.16, con un mínimo de $13.49 y un máximo de $16.84.
En Dec de 2026, se proyecta que Beam Therapeutics Inc. promedie $12.36, con un mínimo de $11.13 y un máximo de $14.05.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.